The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model (2023)
- Authors:
- Autor USP: COSTA, DIEGO LUÍS - ICB
- Unidade: ICB
- DOI: 10.1101/2023.08.09.552716
- Subjects: IMUNOLOGIA; TUBERCULOSE; MYCOBACTERIUM TUBERCULOSIS; INFECÇÕES BACTERIANAS GRAM-POSITIVAS; RESISTÊNCIA MICROBIANA ÀS DROGAS; QUIMIOTERAPIA; ADJUVANTES IMUNOLÓGICOS; INIBIDORES DE ENZIMAS; CAMUNDONGOS; MODELOS ANIMAIS DE DOENÇAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: American Society for Microbiology
- Publisher place: Washington, DC
- Date published: 2023
- Source:
- Título: Antimicrobial Agents and Chemotherapy
- ISSN: 0066-4804
- Volume/Número/Paginação/Ano: v. 68, n. 2, art. e01043-23, 34 p., 2024
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
CASTILLO, Jennie Ruelas et al. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, v. 68, n. 2, p. 34 , 2023Tradução . . Disponível em: https://doi.org/10.1101/2023.08.09.552716. Acesso em: 28 dez. 2025. -
APA
Castillo, J. R., Neupane, P., Karanika, S., Krug, S., Quijada, D., Garcia, A., et al. (2023). The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, 68( 2), 34 . doi:10.1101/2023.08.09.552716 -
NLM
Castillo JR, Neupane P, Karanika S, Krug S, Quijada D, Garcia A, Ayeh S, Yilma A, Sher A, Fotouhi N, Serbina N, Karakousis PC, Costa DL. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 68( 2): 34 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.1101/2023.08.09.552716 -
Vancouver
Castillo JR, Neupane P, Karanika S, Krug S, Quijada D, Garcia A, Ayeh S, Yilma A, Sher A, Fotouhi N, Serbina N, Karakousis PC, Costa DL. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 68( 2): 34 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.1101/2023.08.09.552716 - Modulation of inflammation and immune responses by heme oxygenase-1: implications for infection with intracellular pathogens
- Caracterização da infecção experimental de camundongos com isolados de Leishmania braziliensis resistentes e suscetíveis ao antímônio e ao óxido nítrico
- Caracterização da função de células T reguladoras em pacientes infectados com Leishmania braziliensis
- Host-Directed Therapies for Tuberculosis [Editoria]
- Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work?
- Mycobacterium tuberculosis induces Irg1 in murine macrophages by a pathway involving both TLR-2 and STING/IFNAR signaling and requiring bacterial phagocytosis
- Recent advances in host-directed therapies for tuberculosis and malaria
- Crosstalk between heme oxygenase-1 and iron metabolism in macrophages: implications for the modulation of inflammation and immunity
- Limitation of deleterious iNOS-Expressing interstitial macrophages is dependent on protective IL-1α and IL-17 in tuberculosis and existing obesity
- Artepillin C reduces allergic airway inflammation by induction of monocytic myeloid-derived suppressor cells
Informações sobre o DOI: 10.1101/2023.08.09.552716 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
